ACTRN12616000824460已完成2 期
A Single-Center, Randomized, Open-Label, Two-Period, Cross Over, Pharmacokinetic Study to Assess the Relative Bioavailability of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS1) versus NicoDerm (Registered Trademark) CQ (Registered Trademark) Patch in Smokers
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Non-treatment seeking smokers, smoking 11 cigarettes or more per day.
排除标准
- •males who consume more than 4 alcoholic beverages per day
- •females who consume more than 3 alcoholic beverages per day
- •skin tattoos
研究者
相似试验
进行中（未招募）
1 期
A Study to Evaluate the Effects of Food on Pharmacokinetics of AC-101Oral and Gastrointestinal - Inflammatory bowel diseaseInflammatory Bowel DiseaseACTRN12623000243617Accro Bioscience (Australia) Pty Ltd12
已完成
不适用
A bioavailability study to compare two extracts of Indian Frankincense in healthy adults.CTRI/2018/02/011825Arjuna Natural Limited16
终止
1 期
A study to Evaluate the Effects of Food on Pharmacokinetics of AC-201.PsoriasisSkin - Dermatological conditionsACTRN12623000408684Accro Bioscience (Australia) Pty Ltd16
已完成
不适用
Bioequivalence Study of Pramipexole Prolonged Release Tablets 3.15 mg of Mylan Laboratories Ltd., India with Sifrol® 3.15 mg (Pramipexole) depottabletter (depot tablet) of Boehringer Ingelheim International GmbH, Germany in Patients with Idiopathic Parkinsonâ??s disease.CTRI/2016/03/006780MYLAN LABORATORIES LIMITED INDIA40
已完成
不适用
Study of Pazopanib in Advanced Kidney Cancer patientsCTRI/2022/06/043344Eugia Pharma Specialities Limited India56